Dr. David Row, MD

Dr. Row practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Row's NPI, 1871797118, was assigned on June 12, 2007. Dr. Row graduated from Loma Linda University School Of Medicine in 2001. Dr. Row holds California license A120226.

Dr. Row's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Row's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Row is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Row to 1 more group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Row's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Row practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Row's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Row is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Row's licenses on file in 5 states: California, Arizona, Utah, Washington and New York.

Dmand AI lists colonoscopy and hemorrhoids among the conditions Dr. Row treats.

CMS data shows 159 Medicare services from Dr. Row across 7 procedure codes in 2024, for 104 Medicare patients. Medicare paid $17,712 for them.

CMS counts 104 Medicare patients who saw Dr. Row in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Row's median patient age at 62, with 49% women.

In 2024, Dr. Row wrote 173 Medicare Part D claims for 75 patients. 87% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $835 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Row accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of colonoscopy by Dr. Row, more than 54% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Row, published from 2010 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Immunosuppressive Agents and Lung Transplantation. Dr. Row's most frequent co-authors are Ronald Anthony Gagliano, MD, Jonathan L. Dameworth, MD and Ross M. Bremner, MD.

Dmand AI links Dr. Row to 1 clinical trial. Conditions studied include Intestinal Obstruction and Constipation.

CMS Open Payments shows 38 general payments to Dr. Row from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. Intuitive Surgical, Inc. paid the most, $2,774.

Dmand AI lists 2 awards for Dr. Row.

Dr. Row graduated from Loma Linda University School Of Medicine in 2001. Dr. Row is a member of ACS and ASCRS.

Dr. Row is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.